Portland, Maine
ImmuCell broke ground in October of 2016 on a $20 million pharmaceutical manufacturing facility in Portland, Maine. The two-story, 16,800-sf facility will provide fermentation, processing, laboratory, and warehouse space for the production of Nisin, the active ingredient in one of ImmuCell's leading animal health products. Stantec is providing architectural and engineering services for the project, which is being built by Consigli Construction. Completion is expected in late 2017 with manufacturing operations commencing in early 2018.
| Organization | Project Role |
|---|---|
|
Stantec
|
Architect and Engineer
|
|
Consigli Construction Co., Inc.
|
General Contractor
|
Source
